News & Updates

Show Multimedia Only

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

20 Aug 2025 by

Podcast: Professor Flor Munoz discusses the importance of vaccination for pregnant women and children against COVID-19 at IDWeek 2023

20 Aug 2025

Dupilumab eases itch, disease activity in chronic spontaneous urticaria

20 Aug 2025 by

Patients with chronic spontaneous urticaria (CSA) who has uncontrolled disease despite treatment with H1-antihistamines may benefit from using dupilumab, which has been shown to reduce itch and urticaria activity in two phase III trials.

Dupilumab eases itch, disease activity in chronic spontaneous urticaria

20 Aug 2025

Achieving optimal sedation and smooth extubation in ICU settings

16 Jun 2025 by

Pain, agitation and delirium occur frequently in patients admitted to the intensive care unit (ICU). Each of these patients requires a different level of pain control and depth of sedation to achieve optimal outcomes. Dr. George Ng, Specialist in Critical Care Medicine in Hong Kong, shared his experience in the provision of sedation in different ICU settings, focusing on the use of sedatives such as benzodiazepines, propofol and dexmedetomidine (Precedex^®, Hospira [a Pfizer company]) for patients with different disease severity and in the process of extubation.

Achieving optimal sedation and smooth extubation in ICU settings

16 Jun 2025

New paradigms in facial hyperpigmentation management

16 Jun 2025 by

Depigmentation creams and laser therapy have been the mainstay of treatment for facial hyperpigmentation. However, these treatments are not universally effective and some have resulted in worsening of conditions in some patients.

New paradigms in facial hyperpigmentation management

16 Jun 2025

BPaL regimen tied to liver injury

10 Apr 2025

The overall risk of drug-induced liver injury (DILI) with the pretomanid, bedaquiline and linezolid (BPaL) regimen is lower compared with the isoniazid, rifampin, pyrazinamide and ethambutol (HRZE) regimen, a study has shown. However, the association between BPal and DILI remains significant, suggesting the need for careful monitoring during treatment.

BPaL regimen tied to liver injury

10 Apr 2025

Amlodipine makes up half of CCB overdoses; verapamil, diltiazem remain most toxic

09 Apr 2025 by

Among the cases of calcium channel blocker (CCB) overdose, dihydropyridines are the most common, with amlodipine accounting for nearly half. On the other hand, more severe toxicities occur with the use of verapamil and diltiazem.

Amlodipine makes up half of CCB overdoses; verapamil, diltiazem remain most toxic

09 Apr 2025

Esketamine may work against treatment-resistant depression

04 Apr 2025

Treatment with esketamine as an add-on to antidepressants shows modest efficacy in adults with treatment-resistant depression, reports a study. Its effect on suicidality, however, is not significant.

Esketamine may work against treatment-resistant depression

04 Apr 2025

Ganciclovir/valganciclovir tied to adverse effects in preterm infants with CMV

03 Apr 2025 by

Preterm and very low birthweight (VLBW) infants who have been treated with ganciclovir (GCV) or oral valganciclovir (valGCV) for cytomegalovirus (CMV) disease are more likely to experience adverse events than term infants, a study has shown.